-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Cyclo Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Cyclo Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$544K, a 13861% decline year-over-year.
- Cyclo Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$111K, a 32.1% increase year-over-year.
- Cyclo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$7.25K, a 158% decline from 2022.
- Cyclo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $12.5K, a 266% increase from 2021.
- Cyclo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $3.41K, a 82.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)